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Abstract 
 
Background:To determine the etiological spectrum of 
persistent neonatal jaundice, which persists for more than 
two weeks of a neonate’s life  
Methods: In this descriptive study 35 patients with 
persistent neonatal jaundice were included. History, 
presentation, symptoms, signs and diagnostic modalities 
to evaluate the causes of neonatal jaundice were assessed 
Results: Out of total 35 patients, 25 (71%) were found to 
be having conjugated hyperbilirubinaemia while only 10 
(29%) had unconjugated variety. Idiopathic neonatal 
hepatitis (28%) and neonatal sepsis (22%) were the two 
major etiologies observed for persistent neonatal jaundice. 
80% of survival rate was observed and the median age at 
which the jaundice was first noticed was determined to be 
6.23+/-2.28 days. Median age of clinical clearance of 
jaundice in patients with neonatal sepsis was 25 +/- 9.2 
days and in those with neonatal hepatitis  75 +/- 12.6 days. 
Conclusion: Cholestatic jaundice is a major cause of 
persistent neonatal hepatitis and idiopathic neonatal 
hepatitis accounts for the major bulk of these patients. 
Key Words: Neonatal jaundice, Cholestasis, 
Kernicterus 
 
Introduction 
 
Neonatal jaundice is one of the major cause of 
admission in newborn nurseries.1 Jaundice is observed 
during the 1st week of life in approximately 60% of 
term infants and 80% of preterm infants.2 Jaundice that 
persists for more than two weeks of life is called 
persistent neonatal jaundice.10 The common causes of 
prolonged jaundice can be classified into unconjugated 
and conjugated varieties. Persistent unconjugated 
hyperbilirubinaemia includes breast milk jaundice, 
galactosemia, aminoaciduria, intestinal atresia, pyloric 
stenosis, meconium ileus, Hirschsprung disease, 
Cystic fibrosis, hypothyroidism, congenital defects of 
the pituitary or hypothalamus, persistent haemolysis, 
G6PD deficiency, and Crigler Najjar, Gilbert 
syndromes and Zellweger syndrome. 4-6 Persistent 
conjugated hyperbilirubinaemia  includes idiopathic 
neonatal hepatitis, congenital TORCH or acquired 
infections, hyper alimentation-associated cholestasis, 
trisomy 21, Dubin Johnson syndrome, Rotor 
syndrome, alpha 1 antitrypsin deficiency, intra or extra 
hepatic biliary atresia, neonatal haemochromatosis, 
biliary hypoplasia, progressive familial neonatal 
cholestasis including Byler’s syndrome and Alagile’s 
syndrome. 7-8 Rarely, physiologic jaundice may be 
prolonged for several weeks. It is important that  all 
patients with persistent neonatal jaundice should be 
evaluated in a staged approach as early as possible . 
 
Patients and Methods 
 
This descriptive study was carried out at MH 
Rawalpindi from August 2006 to January 2007. During 
this 6 month period, a total of 35 patients with 
persistent neonatal jaundice (jaundice appearing 
before two weeks and persisting after two weeks of 
life) admitted either in paediatric ward or neonatal 
intensive care unit, were selected with nonprobability 
convenience sampling.  
Detailed information of neonatal jaundice was 
obtained regarding its onset, progression and 
associated symptoms. Detailed history including 
family, gestational and birth events was obtained. 
Thorough physical examination including degree of 
icterus, pallor, neurological assessment and naked eye 
examination of stool was done. Both direct and 
indirect fractions of bilirubin in the serum were 
determined. Neonates were further investigated in the 
light of gathered information and the provisional 
diagnosis  
 
Results 
 
Out of total 35 patients with persistent 
neonatal jaundice, 25 (71%) were found to have 
conjugated hyperbilirubinaemia and only 10 (29%) had 
unconjugated variety. Idiopathic neonatal hepatitis 
(28%) and neonatal sepsis (22%) were the two major 
etiologies observed for persistent neonatal 
jaundice(Table  1).Idiopathic hepatitis was more 
common in term babies (80%) while neonatal sepsis 
was more prevalent in preterm babies (62%). 
Among the aetiology of conjugated 
hyperbilirubinaemia (neonatal cholestasis), 
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hepatocellular causes accounted for 52% of the total 
cases followed by sepsis and obstructive pathologies 
(Table  2).  
 
Table 1:Persistent Neonatal 
Jaundice:Aetiological spectrum  
Aetiology No of Cases % Age 
Idiopathic Neonatal  
    Hepatitis  
10 28% 
Neonatal Sepsis 8 22% 
Biliary Atresia 3 8% 
Hypothyroidism  2 6% 
G6PD Deficiency  2 6% 
Down Syndrome 2 6% 
Galactosemia 2 6% 
Carolli’s Disease 1 3% 
Congenital    
   Dyserythropoietic 
     Anaemia  
1 3% 
TPN Related 
Cholestasis 
1 3% 
Undiagnosed  3 8% 
Total 35 100% 
 
 
Table 2:Spectrum of neonatal cholestasis 
Diagnosis No. of 
Cases  
% Age 
Hepatocellular Causes  
Idiopathic Neonatal Hepatitis 
Metabolic (Galactosemia) 
Varied (TPN) 
 
10 
2 
1 
 
40% 
8% 
4% 
Obstructive Causes  
Biliary Atresia  
Carolli’s Disease  
 
3 
1 
 
12% 
4% 
Sepsis  8 32% 
 
Male patients were 19 (54%) and female 
patients were 16 (46%) with M: F of 1.2:1. There was a 
family history of neonatal jaundice requiring 
investigations in 1 patient whereas consanguinity was 
reported in 21 cases. Jaundice was first noted at the 
median age of 6.23 +/- 2.28 days. Gestational age was 
negatively correlated with the length of cholestasis 
with preterm babies taking longer time to clear their 
jaundice. Median age of clinical clearance of jaundice 
in patients with neonatal sepsis was found to be 25 +/- 
9.2 days and those with neonatal hepatitis as 75 +/- 
12.6 days. 28 (80%) patients survived while 7 (20%) 
expired. Other than jaundice as main clinical feature 
most of these patients had failure to thrive, feeding 
difficulties and hepatosplenomegaly (Table 3). 
 
Table 3:Persistent neonatal jaundice: 
Spectrum of clinical features 
Clinical Features No. of Cases % Age 
Icterus  35 100% 
Failure to Thrive  21 60% 
Organomegaly  21 60% 
Feeding Difficulties  20 57% 
Listlessness  20 57% 
Abdominal Distension  17 48% 
Passage of Acholic Stools  9 26% 
Pallor  7 20% 
 
Discussion 
 
Many infants are affected by jaundice, some 
are even born with it, but it is rarely mentioned, 
though a great many die of it. The diagnosis and 
management of this condition in infants, especially 
with persistent jaundice, continues to be a daunting 
task. Prompt and proper investigation of these babies 
is important in diagnosing treatable causes. Persistent 
jaundice can lead to malabsorption leading to failure 
to thrive; hence these babies need more calories to 
maintain satisfactory growth which is very important 
in first few years of life. These babies may develop fat 
soluble vitamin deficiency states and require vitamins 
A, D, E, and K supplementation. They are at special 
risk of life threatening bleeding or brain damage from 
vitamin K responsive hemorrhagic disease.  
In present study, of 25 observed cases of 
neonatal cholestasis,idiopathic neonatal hepatitis 
accounted for 40%, neonatal sepsis 32%, obstructive 
causes 16%, metabolic 8% and others 4%.Some what 
comparable results were observed by Yachha et al  
showing hepatocellular causes accounting for 53% 
(neonatal hepatitis 47%, metabolic 4% and 2% due to 
varied etiology), obstructive causes in 38% (biliary 
atresia 34%, choledochal cyst 4%), ductal paucity in 3% 
and other 6% cases were idiopathic.9 Similar study by 
Bansal et al observed 44.4% patients with idiopathic 
neonatal hepatitis,22% biliary atresia,2.4% cysts and 
rest accounted for by miscellaneous etiologies.10 In 
contrast  to our observation a study done in 
Rawalpindi showed that biliary atresia (62%) was 
predominant etiology in patients presenting with 
neonatal cholestasis followed by neonatal hepatitis 
(27%). 11 Kaplan et al in a study have shown 55% 
incidence of neonatal jaundice in Down Syndrome.12 
However, we  recorded only 2 patients with persistent 
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neonatal jaundice. A study done at Lahore showed 
that 10% of jaundiced babies were G6PD deficient 
which is  close to 6% observed in our study.13 
 
Conclusion 
 
1.All newborn babies presenting with persistent 
neonatal jaundice should be promptly investigated to 
search for underlying treatable conditions. 
2. Cases with suspected extra hepatic biliary atresia 
(EHBA) should be referred to paediatric surgery, 
urgently   
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